Biosimilars Clinical Trials | Amgen Biosimilars
AbbVie, Amgen, Takeda Pharma launch joint trial of coronavirus medicines
Clinical Trials | Amgen
Amgen unveils its KRas inhibitor in human clinical trials
Clinical Trials | Amgen
A Strategy for Making Clinical Trials More Successful | Amgen
Accelerating R&D to Speed Medicines to Patients | Amgen
Clinical Trials | Amgen
Clinical Trials | Amgen
Amgen taps Syapse to infuse real-world data into its cancer clinical trial designs | Fierce Biotech
Biosimilars Clinical Trials | Amgen Biosimilars
FDA approves Amgen drug for lung cancer with specific mutation
Amgen scientists' rapid work to challenge the undruggable KRAS G12C mutation in cancer
Biosimilars Clinical Trials | Amgen Biosimilars
Amgen deploys StudyTeam enrollment software
How Amgen Is Taking An Adaptive Approach To Clinical Trials
Amgen | A Worldwide Pioneer in Biotechnology
AMGEN at the American College of Cardiology's (ACC) Annual Meeting
Clinical Trials | Amgen
Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies Of Rilotumumab In Advanced Gastric Cancer
Amgen Psoriatic Arthritis Clinical Trials - Advanced Rheumatology of Houston
A Strategy for Making Clinical Trials More Successful | Amgen
Amgen - Wikipedia
Inside Amgen's Push for Greater Diversity in Clinical Trials | Amgen
